Insights in Gynecologic Oncology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Editorial   
  • Current Trends Gynecol Oncol 9;211,

The Role of Endometrial Ablation in Treating Uterine Fibroids

Mary Lake Polan*
Department of Medical Oncology, Maastricht Medical Centre, GROW, Maastricht, Netherlands
*Corresponding Author : Mary Lake Polan, Department of Medical Oncology, Maastricht Medical Centre, GROW, Maastricht, Netherlands, Email: Polan@gmail.com

Received Date: Apr 02, 2024 / Published Date: Apr 30, 2024

Abstract

Uterine fibroids, or leiomyomas, are benign tumors of the uterus that affect a significant number of women, often leading to symptoms such as heavy menstrual bleeding, pelvic pain, and pressure symptoms. Endometrial ablation (EA) has emerged as a minimally invasive treatment option for women suffering from fibroid-related symptoms. This article reviews the role of endometrial ablation in managing uterine fibroids, examining its efficacy, safety, indications, and patient outcomes.

Citation: Mary LP (2024) The Role of Endometrial Ablation in Treating UterineFibroids. Current Trends Gynecol Oncol, 9: 211.

Copyright: © 2024 Mary LP. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top